Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Feb;4(1):81-87.
doi: 10.1007/s11908-002-0071-6.

Treatment of Primary HIV

Affiliations

Treatment of Primary HIV

Joanne Stekler et al. Curr Infect Dis Rep. 2002 Feb.

Abstract

Primary HIV-1 infection refers to the events surrounding the acquisition of HIV-1 infection. It is commonly associated with a nonspecific clinical syndrome that occurs within 2 to 4 weeks after exposure in 40% to 90% of persons acquiring HIV-1. Patients identified prior to seroconversion often have plasma titers in excess of 500,000 copies/mL. Over time, plasma HIV-1 RNA titers decrease and eventually reach a "set point." Treatment of primary HIV-1 infection with highly active antiretroviral therapy does not prevent establishment of chronic infection. However, it potentially may decrease the viral set point, prevent evolution of resistant mutants, preserve immune function, improve clinical outcome, and possibly allow for viral control after withdrawal of antiretroviral therapy. Transmission of viral strains with decreased susceptibility to antiviral drugs increases the difficulty of choosing an antiretroviral regimen. Other medications, including immunomodulators, are under study as adjuvant therapy for treatment of primary HIV-1 infection.

PubMed Disclaimer

References

    1. Ann Intern Med. 1996 Aug 15;125(4):257-64 - PubMed
    1. J Infect Dis. 1999 Mar;179(3):527-37 - PubMed
    1. J Infect Dis. 2001 May 15;183(10):1466-75 - PubMed
    1. Science. 1999 Feb 5;283(5403):857-60 - PubMed
    1. Ann Intern Med. 1998 Jun 15;128(12 Pt 2):1079-100 - PubMed

LinkOut - more resources